A patient with a history of poorly controlled diabetes presents with worsening numbness and tingling in her feet, dizziness, and an unsteady gait. Her blood pressure is 150/95 mmHg, blood glucose is 210 mg/dL, and her hemoglobin A1c is 9.2%. Which intervention should the nurse prioritize to address the patient's risk of further complications?

B) Educate the patient on the importance of regular blood glucose monitoring and adherence to her diabetic regimen.

A) Encourage the patient to increase her dose of statin medication.

B) Educate the patient on the importance of regular blood glucose monitoring and adherence to her diabetic regimen.

C) Advise the patient to increase her dietary sodium intake to manage dizziness.

D) Suggest the patient perform daily foot inspections to monitor for injuries.

A patient with a history of type 2 diabetes mellitus presents with worsening numbness and tingling in her feet, dizziness, unsteady gait, and elevated blood pressure of 150/95 mmHg. Her laboratory tests reveal a hemoglobin A1c of 9.2% and microalbuminuria. Which intervention should the nurse prioritize to address the underlying pathophysiology of these symptoms?

D) Facilitate the initiation of an SGLT2 inhibitor to improve glycemic control and provide renal protection.

A) Educate the patient on the importance of dietary modifications to manage blood glucose levels.

B) Encourage the patient to increase physical activity to improve peripheral circulation.

C) Administer an antihypertensive medication to manage elevated blood pressure.

D) Facilitate the initiation of an SGLT2 inhibitor to improve glycemic control and provide renal protection.

A patient with type 2 diabetes mellitus is experiencing an increased frequency in urination and mild episodes of hypoglycemia after starting an SGLT2 inhibitor. The patient also has a new diagnosis of peripheral neuropathy and is on gabapentin therapy. Considering the patient's current complications and treatment plan, which nursing intervention is the priority?

B) Advise the patient to increase fluid intake to prevent dehydration and monitor for signs of acute kidney injury.

A) Educate the patient on the importance of consistent carbohydrate intake to prevent hypoglycemia.

B) Advise the patient to increase fluid intake to prevent dehydration and monitor for signs of acute kidney injury.

C) Recommend the patient perform daily foot inspections to prevent complications from peripheral neuropathy.

D) Adjust the timing of antihypertensive medications to reduce the risk of orthostatic hypotension.

A patient with type 2 diabetes is experiencing episodes of acute kidney injury (AKI) potentially related to SGLT2 inhibitor therapy and dehydration. Which nursing intervention is most appropriate to prevent further kidney damage while addressing the patient's current symptoms?

A) Encourage the patient to increase fluid intake and monitor for signs of dehydration.

B) Reinstitute the SGLT2 inhibitor at a lower dose to manage blood glucose levels effectively.

C) Increase the dosage of antihypertensive medication to stabilize fluctuating blood pressure.

D) Advise the patient to limit physical activity to prevent strain on the kidneys.

A patient with type 2 diabetes mellitus and peripheral neuropathy is experiencing worsening neuropathic pain despite an optimized gabapentin regimen. Which nursing intervention would be most appropriate to address the patient's increased fall risk due to neuropathy?

C) Collaborate with the physiotherapist to enhance balance and strength training exercises.

A) Encourage the patient to perform daily foot checks independently.

B) Advise the patient to limit physical activity to prevent pain exacerbation.

C) Collaborate with the physiotherapist to enhance balance and strength training exercises.

D) Increase the patient's gabapentin dose to further alleviate pain symptoms.

A patient with type 2 diabetes mellitus has been experiencing worsening peripheral neuropathy symptoms, including burning sensations and tingling in her feet. Her healthcare team has increased her gabapentin dosage and incorporated balance exercises to reduce fall risk. Which nursing intervention is most appropriate to prioritize in managing her neuropathic pain while minimizing the risk of falls?

A) Encourage the patient to take gabapentin at bedtime to minimize daytime sedation.

B) Advise the patient to perform balance exercises before taking gabapentin.

C) Instruct the patient to monitor blood glucose levels more frequently.

D) Suggest the patient increase dietary fiber intake to improve medication absorption.

A patient with newly diagnosed left ventricular hypertrophy and mild diastolic dysfunction is started on an ACE inhibitor. Which nursing intervention is MOST important to implement when initiating this medication?

D) Assess the patient for symptoms of orthostatic hypotension.

A) Monitor the patient for signs of hyperkalemia.

B) Educate the patient on the importance of reducing dietary sodium.

C) Encourage the patient to increase their fluid intake.

D) Assess the patient for symptoms of orthostatic hypotension.

A patient with newly diagnosed mild diastolic dysfunction is started on an ACE inhibitor as part of her cardiovascular management. Which nursing intervention is most important to implement initially to ensure patient safety following the initiation of this medication?

A) Monitor for signs of angioedema, such as swelling of the face or lips

B) Educate the patient about the potential for a dry cough and when to report it

C) Assess the patient's blood pressure and renal function regularly

D) Encourage the patient to increase fluid intake to avoid dehydration

A patient with diabetes and hypertension has been started on an ACE inhibitor and presents with mild peripheral edema and a slight increase in serum creatinine and potassium levels. Which nursing intervention is the most appropriate to address the patient's current condition?

B) Educate the patient on the importance of adhering to a low-sodium diet.

A) Advise the patient to increase fluid intake to flush out excess potassium.

B) Educate the patient on the importance of adhering to a low-sodium diet.

C) Recommend the patient to discontinue the ACE inhibitor immediately.

D) Suggest the patient to use a compression stocking to manage edema.

A patient with diabetes and hypertension has been started on an ACE inhibitor. She reports decreased shortness of breath, but the nurse notes mild peripheral edema and laboratory results show an increase in serum creatinine and potassium levels. Which nursing intervention is most appropriate at this time to address the patient's condition?

B) Educate the patient on a low-potassium diet to manage hyperkalemia.

A) Increase the dose of the ACE inhibitor to improve blood pressure control.

B) Educate the patient on a low-potassium diet to manage hyperkalemia.

C) Discontinue the ACE inhibitor immediately to prevent renal damage.

D) Recommend the patient to reduce fluid intake to manage edema.

Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance - In type 2 diabetes, cells in the body become less responsive to insulin, leading to decreased glucose uptake and increased blood glucose levels. This is often linked to obesity and a sedentary lifestyle.

• Secondary mechanism: Beta-cell dysfunction - The pancreatic beta cells, responsible for insulin production, fail to meet the body's increased demand for insulin, worsening hyperglycemia over time.

• Key complication: Chronic hyperglycemia - Persistently high blood glucose levels cause damage to blood vessels, leading to complications such as neuropathy, retinopathy, and nephropathy, significantly impacting patient quality of life.

Patient Profile

Demographics:

58-year-old female, accountant

History:

• Key past medical history: Diagnosed with Type 2 Diabetes 8 years ago, hypertension, and hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 40 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing numbness and tingling in feet

• Key symptoms: Fatigue, blurred vision, frequent urination, occasional headaches

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 190 mg/dL

Section 1

New Complications:

During a follow-up visit, the patient reports worsening numbness and tingling in her feet, now extending to her lower legs. She also mentions a recent episode of dizziness and an unsteady gait, which led to a minor fall at home. Upon examination, her pedal pulses are diminished, and there is decreased sensation to light touch and vibration in her feet and lower legs. Her blood pressure has increased to 150/95 mmHg, and her blood glucose level remains elevated at 210 mg/dL, indicating poor glycemic control.

Laboratory tests reveal a hemoglobin A1c of 9.2%, suggesting chronic hyperglycemia. Additionally, a microalbuminuria test shows elevated levels, indicating early signs of diabetic nephropathy. These findings, combined with her symptoms, suggest progression of diabetic neuropathy and possible orthostatic hypotension due to autonomic neuropathy. The patient's lipid profile remains high, with LDL cholesterol at 140 mg/dL, despite ongoing statin therapy, increasing her risk for cardiovascular complications.

These developments necessitate a comprehensive review of her current management plan. The healthcare team considers intensifying her diabetic regimen, potentially introducing an SGLT2 inhibitor or GLP-1 receptor agonist to better control her blood glucose levels and provide renal protection. Additionally, a referral to a neurologist for further evaluation of her neuropathy and a plan for lifestyle modifications, including dietary changes and increased physical activity, are recommended to address her modifiable risk factors. These steps are crucial to prevent further complications and improve her overall quality of life.

Section 2

The patient's healthcare team decides to begin the intensified diabetic regimen by adding an SGLT2 inhibitor to her treatment plan. Over the following weeks, the patient reports some improvement in her blood glucose levels, with her daily readings now averaging around 170 mg/dL. However, she experiences increased frequency in urination and mild episodes of hypoglycemia, particularly in the late afternoon. Her blood pressure readings fluctuate, with occasional drops to 110/70 mmHg, raising concerns about the potential for orthostatic hypotension. The team monitors her closely, adjusting her antihypertensive medications to stabilize her blood pressure without exacerbating the risk of falls.

A follow-up appointment with the neurologist confirms the presence of peripheral neuropathy, and a nerve conduction study reveals slowed nerve signals in her lower extremities. The neurologist recommends starting a course of gabapentin to manage her neuropathic pain and suggests incorporating balance exercises into her physiotherapy regimen to address her unsteady gait. The patient's lipid profile remains a concern, despite adherence to statin therapy, prompting the consideration of adding ezetimibe to further lower her LDL cholesterol levels.

Despite these interventions, the patient experiences a new complication: an episode of acute kidney injury (AKI), likely precipitated by the combination of SGLT2 inhibitor therapy and dehydration from increased urination. Her serum creatinine levels rise to 2.0 mg/dL, and her estimated glomerular filtration rate (eGFR) decreases to 45 mL/min/1.73m². The healthcare team temporarily discontinues the SGLT2 inhibitor and emphasizes the importance of maintaining adequate hydration. This setback highlights the need for ongoing monitoring and adjustment of her treatment plan, underscoring the complexity of managing multiple, interrelated diabetic complications.

Section 3

New Complications:

After the temporary discontinuation of the SGLT2 inhibitor, the healthcare team closely monitors the patient's renal function and hydration status. Over the following days, there is a gradual improvement in her kidney function, with serum creatinine levels decreasing to 1.6 mg/dL and eGFR improving to 54 mL/min/1.73m². However, the patient begins to exhibit signs of worsening peripheral neuropathy, including more frequent burning sensations and tingling in her feet, accompanied by occasional shooting pains. These symptoms interfere with her ability to perform daily activities, increasing her risk of falls and impacting her quality of life.

In light of these developments, the team reassesses her medication regimen and decides to optimize her neuropathic pain management. The dosage of gabapentin is carefully titrated upwards, balancing efficacy with the risk of side effects such as dizziness or sedation, which could further exacerbate her unsteady gait. Additionally, the physiotherapist intensifies her balance exercises, incorporating proprioceptive training and strength-building activities tailored to improve her lower extremity stability and reduce fall risk. A comprehensive foot care regimen is reinforced to prevent potential diabetic foot ulcers, a known risk with her level of neuropathy.

Despite these proactive measures, the patient's lipid profile remains suboptimal. Her LDL cholesterol level is persistently elevated at 130 mg/dL, prompting the team to introduce ezetimibe in conjunction with her existing statin therapy. Regular follow-ups are scheduled to evaluate the effectiveness of this combination in achieving target lipid levels and to reassess her overall cardiovascular risk profile. This multifaceted approach highlights the ongoing challenge of balancing her complex treatment needs while minimizing the risk of further complications, necessitating vigilant monitoring and collaboration among her healthcare providers.

Section 4

Over the next few weeks, the patient begins to experience increased fatigue and shortness of breath, raising concerns about potential cardiac involvement. A thorough cardiovascular assessment is conducted, revealing mildly elevated blood pressure at 148/92 mmHg and a resting heart rate of 96 beats per minute. An electrocardiogram (ECG) shows no acute ischemic changes, but there is evidence of left ventricular hypertrophy, suggesting chronic cardiac strain potentially exacerbated by persistent hypertension and dyslipidemia. A follow-up echocardiogram confirms mild diastolic dysfunction, prompting the healthcare team to intensify her cardiovascular management plan.

The patient's response to the adjusted neuropathic pain regimen shows a moderate improvement in her symptomatology. She reports a decrease in the frequency and intensity of burning sensations and shooting pains in her feet, which has slightly improved her functional capacity and reduced her fear of falling. However, she still experiences occasional dizziness, likely related to the increased gabapentin dose, necessitating careful monitoring and potential future adjustments.

In light of the new cardiovascular findings, the team introduces an ACE inhibitor to improve cardiac function and better control her blood pressure. The patient's overall management plan is revisited to ensure a holistic approach, considering her renal status, neuropathic pain, and cardiovascular health. The collaborative efforts of the multidisciplinary team aim to stabilize her condition, prevent further complications, and maintain her quality of life. Regular monitoring and follow-up appointments are scheduled to reassess her progress and optimize her treatment plan as needed, highlighting the importance of dynamic and integrated care in managing her complex case.

Section 5

Two weeks following the introduction of the ACE inhibitor, the patient returns for a follow-up appointment. During the visit, she reports a noticeable reduction in her shortness of breath and a slight improvement in her energy levels. However, the nurse observes that the patient's ankles appear swollen, raising concerns about potential fluid retention. A physical examination confirms mild peripheral edema in the lower extremities. The patient's blood pressure has decreased to 138/88 mmHg, and her heart rate is now 88 beats per minute, indicating some improvement in cardiovascular control.

Laboratory tests are conducted to further evaluate her condition. The results reveal a slight increase in her serum creatinine level, now at 1.4 mg/dL, which is higher than her baseline but still within acceptable limits. Her potassium level is slightly elevated at 5.2 mEq/L, suggesting a need for careful monitoring due to the introduction of the ACE inhibitor. Given these findings, the healthcare team decides to adjust her diuretic regimen to address the edema while monitoring her renal function and electrolyte balance closely.

The patient's management plan is updated to include dietary modifications, emphasizing a low-sodium diet to help manage both her blood pressure and fluid retention. The team schedules more frequent follow-up visits to closely monitor her response to these interventions and prevent any further complications. Through these steps, the multidisciplinary team aims to maintain a delicate balance in managing her diabetes-related complications, underscoring the importance of integrating clinical reasoning and patient-centered care in navigating her complex health needs.